Zobrazeno 101 - 110
of 269
pro vyhledávání: ''
Autor:
Jacqueline Saw, Paul A. Friedman, Sorin V. Pislaru, David R. Holmes, Thomas M. Munger, Claire E. Raphael
Publikováno v:
EuroIntervention. 13:1218-1225
Left atrial appendage (LAA) closure for stroke prevention in the setting of non-valvular atrial fibrillation is an alternative to oral anticoagulation in patients with increased bleeding risk. It allows similar reduction in thromboembolic events, in
Autor:
Priyadarshini Arambam, Brian Pinto, Gurpreet Singh Wander, Sripal Bangalore, Prashant Jagtap, Shireesh Sathe, Praveen K. Goel, Ajit Bhagwat, Upendra Kaul
Publikováno v:
EuroIntervention. 13:1194-1201
Aims The aim of this study was to report whether the superiority of the everolimus-eluting stent (EES) vs. the paclitaxel-eluting stent (PES) at one-year follow-up in the Taxus Element versus Xience Prime in a Diabetic Population (TUXEDO)-India trial
Autor:
Justin M. Fox, Rob Eerdekens, Jose F. Chavez, Lukas R.C. Dekker, Nils P. Johnson, James D. Flaherty
Publikováno v:
EuroIntervention, 13(8), 953-961. EuroPCR
Aims: This study independently evaluated the diagnostic performance of electrocardiographic (ECG) criteria to predict the infarct-related artery (IRA) in patients with an acute ST-segment elevation myocardial infarction (STEMI). While a number of ECG
Autor:
Antonio H. Frangieh, Heribert Schunkert, Massimiliano Fusaro, Salvatore Cassese, Nina R Schäffer, Ilka Ott, Jonathan Michel, Roisin Colleran, Constanza Pellegrini, Anupama Shivaraju, Albert M. Kasel, Patrick Mayr, Oliver Husser, Adnan Kastrati, Christian Hengstenberg
Publikováno v:
EuroIntervention. 13:928-934
Aims The aim of this study was to evaluate vascular complications using the "parallel suture technique" in patients receiving an Edwards SAPIEN XT (SXT) or SAPIEN S3 (S3) transcatheter heart valve (THV). Methods and results Two hundred consecutive pa
Publikováno v:
EuroIntervention. 13:e1058-e1066
This study aimed to assess survival and causes of death in a real-world TAVR population as compared to an age- and sex-matched background population.Each aortic stenosis (AS) patient treated with TAVR in Eastern Denmark between 2007 and 2014 (n=617)
Autor:
Joon Hyung Doh, Jinlong Zhang, Hong-Seok Lim, Myeong-Ho Yoon, Seung-Jea Tahk, Doyeon Hwang, Bon Kwon Koo, Ki Hong Choi, Joo Myung Lee, Jonghanne Park, Chang-Wook Nam, Eun Seok Shin
Publikováno v:
EuroIntervention. 13:e1112-e1119
AIMS There are limited data on the prognosis of deferred non-culprit lesions in patients with acute coronary syndrome (ACS) based on fractional flow reserve (FFR). We aimed to investigate the prognosis of deferred non-culprit lesions in ACS patients,
Autor:
Maike Bestehorn, Rajendra H. Mehta, Holger Eggebrecht, Kurt Bestehorn, Karl-Heinz Kuck, Eckart Fleck
Publikováno v:
EuroIntervention. 13:914-920
AIMS Previous studies have shown lower rates of in-hospital complications and mortality for patients undergoing surgical aortic valve replacement (sAVR) in high-volume compared with lower-volume hospitals. It was the aim of our study to analyse wheth
Autor:
Anselm Uebing, Simon J. Davies, Cesare Quarto, James S.M. Yeh, Neil Moat, Anan Daqa, Alison Duncan
Publikováno v:
ResearcherID
Aims Transcatheter mitral valve replacement (TMVR) is a novel technique for treating mitral regurgitation. We report 18-month/two-year outcomes of the five first-in-man patients undergoing chronic TMVR with the Tendyne device. Methods and results Fiv
Autor:
Francesco Maisano, Maurizio Taramasso
Publikováno v:
EuroIntervention. 13:AA40-AA50
The assessment and management of tricuspid valve (TV) disease have evolved substantially in recent years. Increased understanding of the long-term adverse consequences of severe tricuspid regurgitation (TR), along with continued advances in surgical
Autor:
Mohammed Barakat, Peyman N. Azadani, Anwar Tandar, Danny Dvir, Ali N. Azadani, Mostafa Abbasi, Koohyar Vahidkhah
Publikováno v:
EuroIntervention. 13:811-819
AIMS There is an increasing awareness of leaflet thrombosis following transcatheter aortic valve implantation (TAVI) and valve-in-valve (ViV) procedures. Nevertheless, the predisposing factors affecting transcatheter aortic valve (TAV) thrombosis hav